Genetic predictors of depressive symptoms in cardiac patients

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 3, 2009, Pages 381-388

  McCaffery, Jeanne M ^a,f   Duan, Qing Ling ^b   Frasure Smith, Nancy ^a,b,c,d,e   Barhdadi, Amina ^c   Lespérance, Francois ^e   Théroux, Pierre ^c   Rouleau, Guy A ^d,e   Dubé, Marie Pierre ^c  

^a MIRIAM HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Weight Control and Center   (United States)

Author keywords

Coronary disease; Depression; Endothelium; Genetics

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CANNABINOID RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MUSCARINIC M2 RECEPTOR; NITRIC ACID DERIVATIVE; SEROTONIN 2A RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEPRESSION; ENDOTHELIAL DYSFUNCTION; FATTY ACID METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION;

ALLELES; CANADA; DEPRESSION; ENDOTHELIAL CELLS; FATTY ACIDS, OMEGA-3; FEMALE; FRANCE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEART DISEASES; HOMOZYGOTE; HUMANS; INFLAMMATION; INTRONS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PREVALENCE; VON WILLEBRAND FACTOR;

EID: 63449116114     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30824     Document Type: Article

References (43)

1. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 1997. 'Vascular depression' hypothesis. Arch Gen Psychiatry 54(10):915-922.
2. Bacanu SA, Devlin B, Roeder K. 2000. The power of genomic control. Am J Hum Genet 66(6):1933-1944.
3. Barrero FJ, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J, Garcia Yebenes J. 2005. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 5(2):135-141.
4. Beck AT, Steer RA, Ball R, Ranieri W. 1996a. Comparison of beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess 67(3):588-597.
5. Beck AT, Steer RA, Brown GK. 1996b. Beck depression inventory-Manual, 2nd edition. San Antonio: The Psychological Corporation, Harcourt, Brace and Company.
6. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J. 2001. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104(12):1336-1342.
7. Blankenberg S, Barbaux S, Tiret L. 2003. Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191-203.
8. Carney RM, Freedland KE, Miller GE, Jaffe AS. 2002. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res 53(4):897-902.
9. Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, MacMurray JP. 2002. Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women. Am J Med Genet 114(5):527-529.
10. Dai K, Gao W, Ruan C. 2001. The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke. Thromb Res 104(6):389-395.
11. Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, Czajkowski SM, Frank E, Frasure-Smith N, Freedland KE, et al. 2006. Assessment and treatment ofdepression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med 68(5):645-650.
12. Davignon J, Roy M. 1993. Familial hypercholesterolemia in French-Canadians: Taking advantage of the presence of a ''founder effect''.AmJ Cardiol 72(10):6D-10D.
13. De Clerck F. 1991. Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 17(Suppl 5):S1-S5.
14. de Jonge P, Ormel J, van den Brink RH, van Melle JP, Spijkerman TA, Kuijper A, van Veldhuisen DJ, van den Berg MP, Honig A, Crijns HJ, et al. 2006. Symptom dimensions ofdepression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 163(1):138-144.
15. Devlin B, Roeder K. 1999. Genomic control for association studies. Biometrics 55(4):997-1004.
16. Egede LE. 2007. Major depression in individuals with chronic medical disorders: Prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 29(5):409-416.
17. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, et al. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6):918-936.
18. Frasure-Smith N, Lesperance F, Julien P. 2004. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55(9):891-896.
19. Hanon O, Seux ML, Lenoir H, Rigaud AS, Forette F. 2003. Hypertension and dementia. Curr Cardiol Rep 5(6):435-440.
20. Heyer E, Tremblay M. 1995. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet 56(4):970-978.
21. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. 1999. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondia-betic subjects: The Hoorn Study. Arterioscler Thromb Vasc Biol 19(12):3071-3078.
22. Kario K, Matsuo T, Kobayashi H, Asada R, Matsuo M. 1996. 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. Arterioscler Thromb Vasc Biol 16(6):734-741.
23. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. 2003. The epidemiology ofmajor depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095-3105.
24. Krishnan KR, McDonald WM. 1995. Arteriosclerotic depression. Med Hypotheses 44(2):111-115.
25. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. 2004. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 161(2):271-277.
26. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. 2004. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66(3):305-315.
27. Li J, Ji L. 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95(3):221-227.
28. McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, DuanQ, Lesperance F. 2006. Common genetic vulnerability to depressive symptoms and coronary artery disease: A review and development of candidate genes related to inflammation and serotonin. Psychosom Med 68(2):187-200.
29. McCaffery JM, Snieder H, Dong Y, de Geus E. 2007. Genetics in psychosomatic medicine: Research designs and statistical approaches. Psychosom Med 69(2):206-216.
30. Otte C, McCaffery J, Ali S, Whooley MA. 2007. Association ofa serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 164(9):1379-1384.
31. Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP. 1999. Factor VIII, von Willebrand factor and the risk of major is chaemic heart disease in the Caerphilly Heart Study. Br J Haematol 105(1):110-116.
32. Salloway S, Malloy P, Kohn R, Gillard E, Duffy J, Rogg J, Tung G, Richardson E, Thomas C, Westlake R. 1996. MRI and neuropsychological differences in early-and late-life-onset geriatric depression. Neurology 46(6):1567-1574.
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425-434.
34. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GD. 2001. Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis 12(8):651-657.
35. Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. 2001. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int J Geriatr Psychiatry 16(3):254-260.
36. Taragano FE, Bagnatti P, Allegri RF. 2005. A double-blind, randomized clinical trial to assess the augmentation with nimodipine ofantidepres-sant therapy in the treatment of''vascular depression''. Int Psychogeriatr 17(3):487-498.
37. Ueno M, Sakamoto H, Liao YJ, Onodera M, Huang CL, Miyanaka H, Nakagawa T. 2004a. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol 122(2):131-137.
38. Ueno M, Sakamoto H, Tomimoto H, Akiguchi I, Onodera M, Huang CL, Kanenishi K. 2004b. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol (Berl) 107(6):532-538.
39. Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, Kwon JM, Wu W, Dick DM, Rice J, et al. 2004. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13(17):1903-1911.
40. Wardlaw JM, SandercockPA, Dennis MS, Starr J. 2003. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34(3):806-812.
41. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. 2002. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23(22):1764-1770.
42. Yarnell J, McCrum E, Rumley A, Patterson C, Salomaa V, Lowe G, Evans A. 2005. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: The MONICA Optional Haemostasis Study. Eur Heart J 26(4):332-342,discussion 317-318.
43. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. 2002. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2):79-91.